Frederick G L Huetwell Professor of Rheumatology and Professor of Internal Medicine
[email protected]
Available to mentor
Dinesh Khanna
Professor
-
MSUCLA, 1237 Murphy Hall x 951419, 2004
-
MB BSUniversity College of Medical Sciences, Dilshad Garden, 1996
-
Center MemberInstitute for Healthcare Policy and Innovation
-
Lescoat A, Zimmermann F, Murray CD, Khanna D, Hughes M, McMahan ZH. Rheumatology (Oxford), 2024 Dec 18;Journal ArticleSystemic sclerosis-related fecal incontinence: a scoping review focusing on a neglected manifestation.
DOI:10.1093/rheumatology/keae691 PMID: 39693125 -
Bale S, Verma P, Yalavarthi B, Bajželj M, Hasan SA, Silverman JN, Broderick K, Shah KA, Hamill T, Khanna D, Sigalov AB, Bhattacharyya S, Varga J. JCI Insight, 2024 Dec 6; 9 (23):Journal ArticleInhibiting triggering receptor expressed on myeloid cells 1 signaling to ameliorate skin fibrosis.
DOI:10.1172/jci.insight.176319 PMID: 39418109 -
Georges GE, Khanna D, Wener MH, Mei MG, Mayes MD, Simms RW, Sanchorawala V, Hosing C, Kafaja S, Pawarode A, Holmberg LA, Kolfenbach J, Furst DE, Sullivan KM, Huang S, Gooley T, Nash RA. Arthritis Rheumatol, 2024 Dec 3;Journal ArticleAutologous non-myeloablative hematopoietic stem cell transplantation for diffuse cutaneous systemic sclerosis: identifying disease risk factors for toxicity and long-term outcomes in a prospective, single-arm trial.
DOI:10.1002/art.43072 PMID: 39624016 -
Cartlidge MK, Brown KK, Chaudhuri N, Corte TJ, Dieudé P, John L, Kelly C, Khanna D, McRorie E, Nicol L, Stewart G, Walsh SLF, Wijsenbeek M, Hirani N, PASSWRD participants . BMC Pulm Med, 2024 Oct 31; 24 (1): 547Journal ArticleA modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease.
DOI:10.1186/s12890-024-03287-0 PMID: 39482644 -
Kortam N, Liang W, Shiple C, Huang S, Gedert R, Clair JS, Sarosh C, Foster C, Tsou P-S, Varga J, Knight JS, Khanna D, Ali RA. Arthritis Res Ther, 2024 Jul 25; 26 (1): 139Journal ArticleElevated neutrophil extracellular traps in systemic sclerosis-associated vasculopathy and suppression by a synthetic prostacyclin analog.
DOI:10.1186/s13075-024-03379-6 PMID: 39054558 -
Ma F, Tsou P-S, Gharaee-Kermani M, Plazyo O, Xing X, Kirma J, Wasikowski R, Hile GA, Harms PW, Jiang Y, Xing E, Nakamura M, Ochocki D, Brodie WD, Pillai S, Maverakis E, Pellegrini M, Modlin RL, Varga J, Tsoi LC, Lafyatis R, Kahlenberg JM, Billi AC, Khanna D, Gudjonsson JE. Nat Commun, 2024 Jan 3; 15 (1): 210Journal ArticleSystems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis.
DOI:10.1038/s41467-023-44645-6 PMID: 38172207 -
Khanna D, Kramer F, Höfler J, Ghadessi M, Sandner P, Allanore Y, Denton CP, Kuwana M, Matucci-Cerinic M, Pope JE, Atsumi T, Bečvář R, Czirják L, De Langhe E, Hachulla E, Ishii T, Ishikawa O, Johnson SR, Riccieri V, Schiopu E, Silver RM, Smith V, Stagnaro C, Steen V, Stevens W, Szücs G, Truchetet M-E, Wosnitza M, Distler O. Rheumatology (Oxford), 2024 Nov 1; 63 (11): 3124 - 3134.Journal ArticleBiomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
DOI:10.1093/rheumatology/keae150 PMID: 38460548 -
Ross L, Hansen D, Proudman S, Khanna D, Herrick AL, Stevens W, Baron M, Nikpour M, Australian Scleroderma Interest Group (ASIG), Canadian Scleroderma Research Group (CSRG), the Scleroderma Clinical Trials Consortium Activity Index Working Group . Arthritis Rheumatol, 2024 Nov; 76 (11): 1635 - 1644.Journal ArticleDevelopment and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index.
DOI:10.1002/art.42939 PMID: 38937146
